Interactions of narcotic antagonists with receptor sites.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D002845:Chromatography; D004361:Drug Tolerance; D004558:Electric Stimulation; D000882:Haplorhini; D006801:Humans; D007700:Kinetics; D007981:Levorphanol / Q000378:metabolism; D008691:Methadone / Q000494:pharmacology; D051379:Mice; D008968:Molecular Conformation; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000378:metabolism / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D013329:Structure-Activity Relationship; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced; D013997:Time Factors
D009292:Narcotic Antagonists; D011955:Receptors, Drug; D007981:Levorphanol; D009270:Naloxone; D009020:Morphine; D001285:Atropine; D000109:Acetylcholine; D008691:Methadone